Transcranial Magnetic Stimulation for Alzheimer's Disease Treatment (TMSAD)
Intervention Based on Transcranial Magnetic Stimulation for Alzheimer's Disease Patients: Randomized Clinical Trial
Sponsor: Consorci Sanitari de Terrassa
A NA clinical study on Alzheimer Disease, this trial is ongoing. The trial is conducted by Consorci Sanitari de Terrassa and has accumulated 10 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Dec 2022 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2021 — Dec 2022 [monthly]
Not Yet Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2019 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2018 — Dec 2019 [monthly]
Not Yet Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Consorci Sanitari de Terrassa
- Universitat Oberta de Catalunya
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.